Angelos M. Stergiou insider trades: SELLAS Life Sciences Group (SLS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Angelos reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 5, 2022 | SLS | ↓ Sell | 6,494 | $2.61 | $17K | Direct | Dec 5, 2022 (0d) |
| Dec 2, 2021 | SLS | ↓ Sell | 2,120 | $6.25 | $13K | Direct | Dec 3, 2021 (1d) |
| Dec 31, 2018 | SLS | ↓ Sell | 23,277 | $1.25 | $29K | Direct | Jan 3, 2019 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SLS insiders
Open-market trades in the last 12 months
About Angelos M. Stergiou's insider trades
Angelos M. Stergiou is President and CEO at SELLAS Life Sciences Group (SLS). Since Dec 31, 2018, Angelos has reported no open-market purchases and 3 sales worth $59K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.